Homeopathic treatment in resistant livedoid vasculopathy: case report

This paper describes the successful outcome of homeopathic treatment in a case of resistant livedoid vasculopathy (LV). LV is a rare disease characterized by chronic recurrent and painful ulceration of the lower limbs, frequently associated to atrophie blanche (AB), probably due to procoagulant conditions. Most literature reports single or very few cases; response to treatment is difficult, even resistant. This patient suffered LV for 7 years before seeking homeopathic treatment; ulcers recurred frequently, at intervals less than 3 months, in spite of continual use of pentoxyfilline. Configuration of signs and symptoms strongly pointed out to the prescription of homeopathic remedy Sepia succus that promptly elicited significant improvement of LV and the patient's overall state (non suppressive treatment). Considerations are made on the value of single case reports and the reliability of prescriptions grounded on consistent signs and coherence among the manifold features of individual disease.

Keywords

homeopathy - livedoid vasculopathy - case report

• References

• 1 Feldaker M., Hines Jr. E.A., Kierland R.R. Livedo reticularis with summer ulcerations. AMA Arch Derm 1955; 72 (01) 31-42.
• 2 Bard J.W., Winkelmann R.K. Livedo vasculitis: segmental hyalinizing vasculitis of the dermis. Arch Dermatol 1967; 96 (05) 489-499.
• 3 Jorizzo J.L. Livedoid vasculopathy: what is it?. Arch Dermatol 1998; 134 (04) 491-493.
• 4 Hairston B.R., Davis M.D., Pittelkow M.R., Ahmed I. Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol 2006; 142 (11) 1413-1418.
• 5 Acland K.M., Darvay A., Wakelin S.H., Russell-Jones R. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome?. Br J Dermatol 1999; 140 (01) 131-135.
• 6 Zecevic R.D. Livedo vasculitis. Vojnosanit Pregl 2001; 58 (03) 263-266.
• 7 Frances C., Barete S. Difficult management of livedoid vasculopathy. Arch Dermatol 2004; 140 (08) 1011
• 8 Lee S.S., Ang P., Tan S.H. Clinical profile and treatment outcome of livedoid vasculitis: a case series. Ann Acad Med Singapore 2003; 32 (06) 835-839.
• 9 Davis M.D., Wysokinski W.E. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: response to warfarin. J Am Acad Dermatol 2008; 58 (03) 512-515.
• 10 Juan W.H., Chan Y.S., Lee J.C., Yang L.C., Hong H.S., Yang C.H. Livedoid vasculopathy: long-term follow-up results following hyperbaric oxygen therapy. Br J Dermatol 2006; 154 (02) 251-255.
• 11 Kreuter A., Gambichter T., Breuckmann F. et al. Pulsed intravenous immunoglobulin therapy in livedoid vasculitis: an open trial evaluating 9 consecutive patients. J Am Acad Dermatol 2004; 51 (04) 574-579.
• 12 Zeni P., Finger E., Scheinberg M.A. Successful use of rituximab in a patient with recalcitrant livedoid vasculopathy. Ann Rheum Dis 2008; 67 (07) 1055-1056.
• 13 Deng A., Gocke C.D., Hess J. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator. Arch Dermatol 2006; 142 (11) 1466-1469.
• 14 Jurj G. Decision making and semiotics: a view in homeopathy. Int J High Dil Res 2008; 7 (23) 103-112.
• 15 Schroyens F. Syhroyens 9.0. Namur:. Archibel, 2006